Phathom Pharmaceuticals (PHAT) EBT Margin (2023 - 2026)
Phathom Pharmaceuticals' (PHAT) quarterly EBT Margin came in at 82.28% in Q1 2026, up 24835.0% year-on-year from N/an in Q1 2025, and down 124.1% on a QoQ basis from 36.72% in Q4 2025.
Phathom Pharmaceuticals (PHAT) EBT Margin (2023 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 4 years of EBT Margin data on file, last reported at 82.28% in Q1 2026.
- On a quarterly basis, EBT Margin rose 24835.0% year-over-year to 82.28% in Q1 2026; TTM through Mar 2026 was 101.39%, a 36151.0% increase from a year earlier, with the FY2025 full-year figure at 133.32%, up 80357.0% from the prior year.
- EBT Margin for Q1 2026 stood at 82.28%, down from 36.72% in the prior quarter.
- Over the last five years, EBT Margin for PHAT reached as high as 36.72% in Q4 2025 and fell as low as 14702.79% in Q4 2023.
- Historically, EBT Margin has averaged 2203.16% across 4 years, with a median of 290.89% in 2025.
- Across the five-year window, EBT Margin surged 1445164 bps in 2024 and surged 21443 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 14702.79% in 2023, then soared by 98 bps to 251.15% in 2024, then surged by 85 bps to 36.72% in 2025, then plunged by 124 bps to 82.28% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 82.28% in Q1 2026, 36.72% in Q4 2025, and 111.53% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Phathom Pharmaceuticals | 951.79 Mn | 768.02 Mn | 46.31 Mn | -82.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.28% |
| Dec 31, 2025 | -36.72% |
| Sep 30, 2025 | -111.53% |
| Jun 30, 2025 | -211.16% |
| Mar 31, 2025 | -330.64% |
| Dec 31, 2024 | -251.15% |
| Sep 30, 2024 | -725.84% |
| Jun 30, 2024 | -1,248.50% |
| Mar 31, 2024 | -4,331.01% |
| Dec 31, 2023 | -14,702.79% |